Hepatitis B screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Recommendations for Persons Who Should Be Tested for HBV Infection: AASLD Practice Guidelines 2009<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref>== | ==Recommendations for Persons Who Should Be Tested for HBV Infection: AASLD Practice Guidelines 2009<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref>== | ||
{{#widget:SchemaSnippet}} | |||
{{cquote|The following groups should be tested for HBV | {{cquote|The following groups should be tested for HBV | ||
infection: | infection: | ||
| Line 11: | Line 12: | ||
*persons who have ever used injecting drugs, dialysis patients, HIV or HCV-infected individuals, pregnant women, and family members, household members, and sexual contacts of HBV-infected persons. | *persons who have ever used injecting drugs, dialysis patients, HIV or HCV-infected individuals, pregnant women, and family members, household members, and sexual contacts of HBV-infected persons. | ||
*Testing for HBsAg and anti-HBs should be performed, and seronegative persons should be vaccinated. ''(Grade I Recommendation)''}} | *Testing for HBsAg and anti-HBs should be performed, and seronegative persons should be vaccinated. ''(Grade I Recommendation)''}} | ||
==Recommendations for HCC Screening: AASLD Practice Guidelines 2009<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref>== | ==Recommendations for HCC Screening: AASLD Practice Guidelines 2009<ref name="pmid15229781">{{cite journal |author=Lok AS, McMahon BJ |title=[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines] |journal=[[Romanian Journal of Gastroenterology]] |volume=13 |issue=2 |pages=150–4 |year=2004 |month=June |pmid=15229781 |doi= |url=http://www.aasld.org/practiceguidelines/documents/bookmarked%20practice%20guidelines/chronic_hep_b_update_2009%208_24_2009.pdf |accessdate=2012-02-10}}</ref>== | ||
Revision as of 13:36, 19 June 2012
Recommendations for Persons Who Should Be Tested for HBV Infection: AASLD Practice Guidelines 2009[1]
| “ | The following groups should be tested for HBV
infection:
|
” |
Recommendations for HCC Screening: AASLD Practice Guidelines 2009[1]
| “ |
1. HBV carriers at high risk for HCC such as Asian men over 40 years and Asian women over 50 years of age, persons with cirrhosis, persons with a family history of HCC, Africans over 20 years of age, and any carrier over 40 years with persistent or intermittent ALT elevation and/or high HBV DNA level >2,000 IU/mL should be screened with US examination every 6-12 months. (Grade II-2) 2. For HBV carriers at high risk for HCC who are living in areas where US is not readily available, periodic screening with AFP should be considered. (Grade II-2) |
” |
References
- ↑ 1.0 1.1 Lok AS, McMahon BJ (2004). "[AASLD Practice Guidelines. Chronic hepatitis B: update of therapeutic guidelines]" (PDF). Romanian Journal of Gastroenterology. 13 (2): 150–4. PMID 15229781. Retrieved 2012-02-10. Unknown parameter
|month=ignored (help)